Ernst Berndt, PhD's Bio
Ernst Berndt, PhD, is the Louis E. Seley Professor in Applied Economics at the MIT Sloan School of Management. He was previously director of the National Bureau of Economic Research Program on Technological Progress and Productivity Measurement.
Berndt’s recent research focuses on the changing dynamics of healthcare industries. He has examined how medical innovations affect the costs of treating selected diseases over time, factors affecting the globalization of clinical trials (particularly in emerging economies), causes of recent cancer drug shortages in the U.S., incentives to research and development into diseases prevalent in low-income countries, how industry funding of the U.S. Food and Drug Administration through user fees has affected review times and safety withdrawal rates, and the impact of direct-to-consumer marketing of prescription pharmaceuticals on drug utilization. In other research, he has assessed how illness and its treatment affect individuals’ ability to function at work. More generally, his research deals with assessing the sources of productivity growth and how productivity is measured. He has implemented methods for adjusting prices for changes in quality in the pharmaceutical, healthcare, personal computer hardware, prepackaged software and personal digital assistant product categories, and has published research on the structure of advertising services industries.
Berndt earned a BA in economics and philosophy from Valparaiso University, and an MS and PhD from the University of Wisconsin. He holds honorary doctorates from Uppsala University in Sweden and the University of Basel in Switzerland.